Incidence and management of interstitial lung disease in patients with advanced cancer treated with anti-programmed death receptor 1 ligand pembrolizumab Meeting Abstract


Authors: Albano, M.; Gordon, R. A.; Rizvi, N. A.; Wolchok, J. D.
Abstract Title: Incidence and management of interstitial lung disease in patients with advanced cancer treated with anti-programmed death receptor 1 ligand pembrolizumab
Meeting Title: 40th Annual Congress of the Oncology Nursing Society (ONS)
Journal Title: Oncology Nursing Forum
Volume: 42
Issue: 2
Meeting Dates: 2015 Apr 22-26
Meeting Location: Orlando, FL
ISSN: 0190-535X
Publisher: Oncology Nursing Society (ONS)  
Date Published: 2015-03-01
Start Page: E223
End Page: E224
Language: English
ACCESSION: WOS:000357901300304
PROVIDER: wos
DOI: 10.1188/15.ONF.E110
Notes: Meeting Abstract: 58 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Naiyer A Rizvi
    166 Rizvi
  3. Ruthann Gordon
    35 Gordon